Research Articles
The Invisible Shield: How Toxicologic Estimation Powers Safer Medicines
Exploring modern toxicologic estimation methods that accelerate drug development while ensuring patient safety through computational models, advanced in vitro systems, and clinical feedback loops.
The Nano-Bio Revolution: How Converging Technologies Are Rewriting the Rules of Cancer Medicine
Exploring the convergence of nanotechnology, biotechnology and AI in transforming cancer treatment during the Fourth Industrial Revolution
Redesigning Life: When Biology Outpaces the Law
Exploring the legal challenges posed by rapid advancements in genetic engineering, AI-powered biology, and nanotechnology
The Measure of Trust: Can India's BIS Standards Become the Global Gold Standard?
Examining whether India's Bureau of Indian Standards (BIS) has the precision, enforceability, and global credibility to become a true global gold standard.
The Green Light of Tomorrow: How Carbon Dots Forged from Nature Are Revolutionizing Medicine
Explore how green carbon dots derived from natural sources are transforming biomedical applications with sustainable nanotechnology.
Liquid Gold: How Cell-Free DNA is Revolutionizing Cancer Detection and Care
Exploring how cell-free DNA is transforming cancer diagnostics and therapeutic monitoring through liquid biopsies.
The Hidden Battlefield: How Ultra-Sensitive MRD Testing is Revolutionizing Multiple Myeloma Treatment
Exploring how next-generation sequencing and flow cytometry are transforming minimal residual disease detection in multiple myeloma treatment.
Dollars and Biomarkers: The Economic Revolution Reshaping Cancer Drug Development
Exploring how biomarkers are transforming the economics of oncology drug development through precision medicine approaches.
Nature's Molecular Armor: How Plant-Derived Cyclotides Are Revolutionizing Cancer Therapy
Discover how plant-derived cyclotides are being engineered to target Hdm2/HdmX and restore p53 function in cancer therapy.
The Time Benders: How Science Conquered a Childhood Aging Disease
The scientific breakthrough behind Zokinvy (lonafarnib), the first FDA-approved drug for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic aging disease.